Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation in Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm - Full Text View

Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation in Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm (APRAISE)

This study is currently recruiting participants.

Verified by Creighton University, January 2009

Sponsored by:	Creighton University
Information provided by:	Creighton University
ClinicalTrials.gov Identifier:	NCT00818012

Purpose

Atrial electromechanical interval will add incremental value in the prediction of recurrence of atrial fibrillation among patients who underwent successful direct current cardioversion for atrial fibrillation.

Condition
Atrial Fibrillation

Genetics Home Reference related topics: Brugada syndrome familial atrial fibrillation short QT syndrome

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation In Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm

Further study details as provided by Creighton University:

Primary Outcome Measures:

Recurrence of Atrial Fibrillation [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	130
Study Start Date:	August 2008
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	19 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Patients in Atrial Fibrillation

Criteria

Inclusion Criteria:

Age greater than or equal to 19 years of age
History of atrial fibrillation with successful cardioversion to sinus rhythm
Informed consent to participate in the study

Exclusion Criteria:

Failure of cardioversion to sinus rhythm
Use of anti-arrythmic drug therapy
Refusal to participate in the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00818012

Locations

United States, Nebraska
Creighton University Medical Center	Recruiting
Omaha, Nebraska, United States, 68131
Contact: Stephanie Maciejewski, PharmD 402-280-4292

Sponsors and Collaborators

Creighton University

More Information

Responsible Party:	Creighton University ( Jason Go, MD )
Study ID Numbers:	08-15050
Study First Received:	January 6, 2009
Last Updated:	January 6, 2009
ClinicalTrials.gov Identifier:	NCT00818012
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Heart Diseases
Atrial Fibrillation
Recurrence
Arrhythmias, Cardiac

Additional relevant MeSH terms:

Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009